A drug with the SMILES Cc1cccc(N2CCN(Cc3cn(C)nc3-c3ccccc3F)CC2)n1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -34.435%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1cccc(N2CCN(Cc3cn(C)nc3-c3ccccc3F)CC2)n1
Cc1cccc(N2CCN(Cc3cn(C)nc3-c3ccccc3F)CC2)n1
1-[[3-(2-fluorophenyl)-1-methylpyrazol-4-yl]methyl]-4-(6-methylpyridin-2-yl)piperazine